Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-522,367
Closed -$16.8M 550
2016
Q3
$16.8M Sell
522,367
-17,793
-3% -$595K 0.89% 17
2016
Q2
$18M Sell
540,160
-5,138
-0.9% -$164K 0.97% 12
2016
Q1
$15.3M Buy
545,298
+37,101
+7% +$1.06M 0.81% 21
2015
Q4
$15.6M Sell
508,197
-5,080
-1% -$160K 0.91% 15
2015
Q3
$15.3M Sell
513,277
-40,661
-7% -$1.3M 0.96% 13
2015
Q2
$17.6M Sell
553,938
-17,098
-3% -$557K 0.94% 12
2015
Q1
$18.8M Buy
571,036
+7,007
+1% +$223K 1% 11
2014
Q4
$16.7M Sell
564,029
-13,185
-2% -$378K 0.9% 15
2014
Q3
$16.2M Sell
577,214
-29,058
-5% -$816K 0.91% 17
2014
Q2
$17.1M Buy
606,272
+11,234
+2% +$320K 0.94% 14
2014
Q1
$18.1M Sell
595,038
-101,453
-15% -$3.02M 1.04% 13
2013
Q4
$20.2M Sell
696,491
-6,780
-1% -$197K 1.04% 13
2013
Q3
$19.2M Sell
703,271
-38,799
-5% -$1.06M 1.09% 10
2013
Q2
$19.7M Buy
+742,070
New +$20.5M 1.2% 11

Other funds holding PFE

Deere & Company's PFE Position: Q4 2016 in Review

Deere & Company sold out of Pfizer (PFE) in Q4 2016, closing a stake of 522,367 shares — an estimated $16.8M sold.

Deere & Company first reported a position in PFE in Q2 2013 and held it in 14 quarters. The position peaked at $20.2M in Q4 2013. 2,059 funds tracked by Wall St. Rank hold PFE as of Q4 2016.

  • Deere & Company reported no remaining Pfizer position as of Q4 2016 after selling out during the quarter.
  • Deere & Company sold 522,367 Pfizer shares in Q4 2016, an estimated $16.8M.
  • Deere & Company first reported a position in Pfizer in Q2 2013 and held it in 14 quarters.
  • Deere & Company's Pfizer position peaked at $20.2M in Q4 2013.
  • 2,059 funds tracked by Wall St. Rank held Pfizer as of Q4 2016.

Based on Deere & Company's 13F filing for Q4 2016, filed 13 Feb 2017.